WEBULL
WebtradeDownload

Keurig Dr Pepper (KDP) Sells Chobani Stake On A Valuation Story That Looks Debatable

Simply Wall St · 2d ago

Keurig Dr Pepper (KDP) is back in focus after agreeing to sell its entire equity stake in Chobani for a total of US$925 million, including a manufacturing facility and warehouse.

Recent trading suggests investors are leaning into that reshaping story. The 30 day share price return of 8.46% and the year to date share price gain of 17.38% point to building momentum around Keurig Dr Pepper, supported by a 1 year total shareholder return of 21.86%.

Spot opportunities around Keurig Dr Pepper's portfolio reshaping by comparing it with a curated 49 high quality undervalued stocks that investors are watching for potential re-ratings.

The Chobani exit gives Keurig Dr Pepper fresh capital and a cleaner story, although the share price has already moved. So where does fair value actually line up compared with the spread of analyst targets and intrinsic estimates?

Most Popular Narrative: 8.7% Undervalued

The most followed narrative pegs Keurig Dr Pepper’s fair value at $35.65, a premium to the last close at $32.55. This frames today’s move around portfolio reshaping in a different light.

Market share gains in iconic liquid refreshment beverage brands, such as Dr Pepper and Canada Dry, alongside newer brands like Electrolit and C4, could drive revenue growth due to increased consumer demand and successful product introductions.

Read the complete narrative. Read the complete narrative.

Want to see what is really backing that valuation gap for Keurig Dr Pepper? The story leans on compounding revenue, thicker margins, and a future earnings multiple that has to shrink, not stretch. Curious which growth path and profit profile need to line up to make that math work?

Result: Fair Value of $35.65 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, the Keurig Dr Pepper story can change quickly if coffee segment weakness persists or if new tariffs and higher input costs squeeze profitability harder than analysts expect.

Find out about the key risks to this Keurig Dr Pepper narrative.

Another Angle On Keurig Dr Pepper’s Valuation

The first narrative leans on future cash flows. A different lens looks at today’s P/E of 32.9x versus a peer average of 24.2x and a fair ratio of 25.4x. That premium suggests investors are already paying up. Is that optimism or valuation risk for someone buying at these levels?

See what the numbers say about this price in our valuation breakdown. See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:KDP P/E Ratio as at Sep 2026
NasdaqGS:KDP P/E Ratio as at Sep 2026

Next Steps

Mixed messages in the Keurig Dr Pepper story, with both risks and rewards in play, make this a moment to move quickly and test the data against your own expectations by reviewing the 2 key rewards and 4 important warning signs.

Looking for more Keurig Dr Pepper style investment ideas?

If Keurig Dr Pepper has sharpened your focus on pricing, quality and risk, then broaden your watchlist now, or you risk missing stronger setups elsewhere.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.